Xeris Biopharma Holdings

Manufacturing · Illinois, United States · 201-500 Employees

View Company Info for Free

Overview

Headquarters

1375 W Fulton St Ste 1300, Chicago, Illi...

Phone Number

(844) 445-5704

Website

www.xerispharma.com

Revenue

$314.9 Million

Stock Symbol

XERS

Industry

Manufacturing

Pharmaceuticals

About Xeris Biopharma Holdings

Xeris Biopharma Holdings, Inc. is a commercial-stage biopharmaceutical company dedicated to developing, manufacturing, and commercializing innovative therapies that address serious chronic and rare medical conditions. The company focuses on advancing pharmaceutical products that improve patient care by enhancing treatment convenience, expanding therapeutic options, and addressing unmet medical needs across multiple disease areas.Explore more

Is this data correct?

View contact profiles from Xeris Biopharma Holdings

SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: XERSShow more

Xeris Biopharma Holdings Org Chart

Phone

Brad Huckabee

Controller

Phone

Mary McNerney

Chief Commercial Officer (Cco)

Phone

Carissa Werlinger

Corporate Controller

Phone

Get the full picture

Allison Wey

Senior VP, Investor Relations & Corporate Com...

Phone

Senior Vice President, Quality and Chief Comp...

Phone

Pricing & Reimbursement Vice President, Marke...

Phone

Vice President, Investor Relations

Phone

Vice President, Investor Relations

Phone

Vice President, Finance

Phone

Get the full picture

Compare Similar Companies to Xeris Biopharma Holdings

Compare insights from companies similar to Xeris Biopharma Holdings, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Xeris Biopharma Holdings

$314.9M

201-500

Public

$663.4M

2005

Brad HuckabeeController

Sagent Pharmaceuticals

$291.3M

201-500

Private

$162M

2006

Donald BullockExecutive VP, Commercial Operations

Eagle Pharmaceuticals

$257.6M

51-200

Public

$200.3M

2007

Valentin CurtInterim Chief Medical Officer

Sucampo Pharmaceuticals

$247.1M

51-200

Private

$293.1M

1996

Timothy SwopeController

UroGen Pharma

$188.7M

201-500

Public

$195M

2004

Mark SchoenbergChief Medical Officer

Optinose

$24.6M

51-200

Public

$630.7M

2010

Pie LabudaVice President, Information Technology

Savient Pharmaceuticals

$17.2M

201-500

Private

1980

Virginia BazaralSenior Director

View Email Formats for Xeris Biopharma Holdings

Xeris Biopharma Holdings Tech Stack

A closer look at the technologies used by Xeris Biopharma Holdings

DocuSign

Drupal

iCIMS

PHP

See more technologies

Top Manufacturing Companies

Frequently Asked Questions Regarding Xeris Biopharma Holdings

What is Xeris Biopharma Holdings's stock symbol?

Xeris Biopharma Holdings's stock symbol is XERS

What is Xeris Biopharma Holdings's official website?

Xeris Biopharma Holdings's official website is www.xerispharma.com

What is Xeris Biopharma Holdings's Revenue?

Xeris Biopharma Holdings's revenue is $314.9 Million

What is Xeris Biopharma Holdings's SIC code?

Xeris Biopharma Holdings's SIC: 28,283

What is Xeris Biopharma Holdings's NAICS code?

Xeris Biopharma Holdings's NAICS: 32,325

How many employees does Xeris Biopharma Holdings have?

Xeris Biopharma Holdings has 201-500 employees

What industry does Xeris Biopharma Holdings belong to?

Xeris Biopharma Holdings is in the industry of: Manufacturing, Pharmaceuticals

What is Xeris Biopharma Holdings competition?

Xeris Biopharma Holdings top competitors include: Eagle Pharmaceuticals, UroGen Pharma, Sagent Pharmaceuticals, Savient Pharmaceuticals

What technology does Xeris Biopharma Holdings use?

Some of the popular technologies that Xeris Biopharma Holdings uses are: DocuSign, Drupal, iCIMS, PHP

How do I contact Xeris Biopharma Holdings?

Xeris Biopharma Holdings contact info: Phone number: (844) 445-5704 Website: www.xerispharma.com

What does Xeris Biopharma Holdings do?

What are Xeris Biopharma Holdings social media links?

Xeris Biopharma Holdings Linkedin page Xeris Biopharma Holdings Twitter page Xeris Biopharma Holdings Facebook page

Who invested in Xeris Biopharma Holdings?

Xeris Biopharma Holdings has 21 investors including McNair Group, Undisclosed, Undisclosed and Undisclosed.

Is Xeris Biopharma Holdings a public company?

Yes, Xeris Biopharma Holdings is a public company and is traded under the symbol XERS

See more information about Xeris Biopharma Holdings

Xeris Biopharma Holdings Latest Hires and Their Positions

Xeris Biopharma Holdings is expanding and recently hired new employees. Here are the latest additions to the team.

Jennifer Angradi

Area Business Endocrinology Rare Disease Specialist

Joined Aug 1, 2026

Phone

Cristi Barnett

Vice President, Investor Relations

Joined Aug 1, 2026

Phone

Todd Hunter

Manager, Territory Business

Joined Jul 1, 2026

Phone

James Snodgrass

Regional Director, Business

Joined Jul 1, 2026

Phone

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.